SUNY Downstate Medical Center

Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial (2023) Azizi M, Saxena M, Wang Y, Jenkins JS, Devireddy C, Rader F, Fisher ND, et al. Journal article LONG-TERM REDUCTION IN MORNING AND NIGHTTIME BLOOD PRESSURE AFTER RENAL DENERVATION: 36-MONTH RESULTS FROM SPYRAL HTN-ON MED PILOT TRIAL (2023) Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Conference contribution Effect of Radiofrequency Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 6-Month Primary Results From the SPYRAL HTN-ON Med Expansion Randomized Trial (2022) Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder R, Pocock S, et al. Conference contribution Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial (2022) Rader F, Kirtane AJ, Wang Y, Daemen J, Lurz P, Sayer J, Saxena M, et al. Journal article Herniation World Federation of Neurosurgical Societies Scale Improves Prediction of Outcome in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage (2022) Raabe A, Beck J, Goldberg J, Źgraggen WJ, Branca M, Marbacher S, D'Alonzo D, et al. Journal article Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial (2022) Weber T, Wassertheurer S, Mayer CC, Hametner B, Danninger K, Townsend RR, Mahfoud F, et al. Journal article LONG-TERM RESULTS FROM THE SPYRAL HTN-ON MED TRIAL: RENAL DENERVATION INCREASES TIME IN BLOOD PRESSURE TARGET RANGE OVER 36 MONTHS (2022) Tsioufis K, Kandzari D, Kario K, Townsend R, Mahfoud F, Weber M, Schmieder R, et al. Conference contribution LONG-TERM RESULTS FROM THE SPYRAL HTN-ON MED TRIAL: RENAL DENERVATION INCREASES TIME IN BLOOD PRESSURE TARGET RANGE OVER 36 MONTHS (2022) Tsioufis K, Kandzari D, Kario K, Townsend R, Mahfoud F, Weber M, Schmieder R, et al. Journal article Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022) Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Journal article Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial (2022) Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Journal article